Certolizumab Pegol 68225-0045
Product NDC
68225-0045- Manufacturer
- Patheon Italia S.p.a
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- April 20, 2008
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Certolizumab Pegol | 200 mg/mL |
Packaging Options(1)
21000 VIAL in 1 CONTAINER (68225-045-01) / 1 mL in 1 VIAL